Disagree! He knows the company and this complex sector well. Unfortunately, the issue is much wider affect the whole generics sector, not just Mayne.
The company is slowly turned back to stable earning and growth, relying less on generic.
It will take some time, we’re heading in the right direction!
CEO Scott Richards - has to go, page-2
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.65 |
Change
0.170(3.79%) |
Mkt cap ! $395.5M | |||
| Open | High | Low | Value | Volume |
| $4.50 | $4.68 | $4.47 | $1.532M | 331.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 206 | $4.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.65 | 262 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.61 |
Change
0.170 ( 2.41 %) |
||||
| Open | High | Low | Volume | ||
| $4.47 | $4.68 | $4.47 | 64875 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| MYX (ASX) Chart |